The conversation around equity in care continues as our co-hosts interview Nasrien Ibrahim, MD, the founder and executive director of the nonprofit The Equity in Heart Transplant Project, Inc. about creative solutions for helping historically excluded and systemically oppressed patients become better candidates for transplant and other advanced heart failure therapies. On From Failure to Function Priya discusses the ALT FLOW trial presented at THT 2023 that looks at using left atrial to coronary sinus shunting to treat symptomatic heart failure; and on HF Rounds Michael reviews a new scientific statement on Natriuretic Peptides from HFSA, JHFS, and ESC-HFA.

Michael Beasley, MD sits down with Jennifer Cowger, MD, MS, one of the co-authors on the recently released HFSA Expert Consensus Statement on the Medical Management of Patients on Durable Mechanical Circulatory Support, to learn key takeaways from the statement.

Our co-hosts interview Paul Heidenreich, MD, FHFSA a co-author of the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure about economic considerations in the management of HF. On "From Failure to Function", Priya dives into the late breaking trials from ACC.23 and Michael reviews three papers on HFpEF on HF Rounds.

Attention aspiring Advanced Heart Failure and Transplant Cardiology faculty, this quick segment is for you! Looking for good advice on succeeding as an early career faculty member? Tune in as Michael Beasley, MD, interviews Preethi Pirlamarla, MD, on her ACC.org publication, Academic Medicine: Demystifying the Appointment Process.

On this quick follow-up to the February episode, Priya Umapthi MD interviews Biykem Bozkurt MD, PhD, FHFSA on CAM - what is it and what are the risks of CAM to GDMT?

Tune into this episode of HF Beat to hear co-hosts Michael Beasley, MD, and Priya Umapathi, MD, discuss complementary and alternative meds in the treatment of HF with guest, Nosheen Reza, MD.

On part two of this episode series, hosts Michael Beasley, MD and Priya Umapathi, MD continue their discussion on the top highlights of 2022 with current HFSA president Dr. John Teerlink. The STRONG-HF clinical trial, the future of Omecamtiv Mecarbil and the METEORIC-HF trial are discussed. Priya introduces her new episode segment "From Failure to Function," which summarizes the latest heart failure research presented at meetings around the world.

Hosts Michael Beasley, MD and Priya Umapathi, MD interview current and immediate past presidents John Teerlink MD, FHFSA, and Mark Drazner MD, MSc, FHFSA on the most significant events that took place in the field of heart failure in 2022 on this two-part series. Part one dives into SGLT2 inhibitors, the rapid uptitration of GDMT, and cardiac xenotransplantation. Michael also delivers HF Rounds, his new segment which features a succinct peek into interesting news from HF journals. Stay tuned for Part II coming in January!

On this episode our host Kevin Shah, MD passes the torch to the new co-hosts of the Heart Failure Beat: Michael Beasley, MD and Priya Umpathi, MD. Tune in and get to know what’s coming up on the podcast in the next year.

Podcast host Kevin Shah, MD, engages  Alanna Morris, MD, and Robert Page, PharmD, co-authors of the HFSA Position Paper The Impact of Healthcare Disparities on Patients with Heart Failure on key takeaways and implications. They unpack a recently published HFSA Position Statement on Disparities in and discuss action items that can be made across systems to help reduce disparities as well as improve access to care for our most vulnerable patients.